Larsen and colleagues [23] studied 183 breast tumours (33 BRCA1, 22 BRCA2) and developed a 110-probe signature to classify BRCA1 breast tumour within the basal-like subtype with an accuracy of 83% (sensitivity: 82%, specificity 85%). The gene discussed is BRCA2; the disease is breast neoplasm.